id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-1098-0002,FDA,FDA-2000-N-1098,Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents,Rule,Direct Final Rule,2015-11-05T05:00:00Z,2015,11,2000-12-12T05:00:00Z,2001-02-27T04:59:59Z,2025-06-13T00:38:05Z,00–31586,0,0,09000064804edc15
FDA-2000-N-1098-0001,FDA,FDA-2000-N-1098,Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents; Companion to Direct Final Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2015-11-05T05:00:00Z,2015,11,2000-12-12T05:00:00Z,2001-02-27T04:59:59Z,2025-06-13T00:37:03Z,00–31587,0,0,09000064804edc14
FDA-2000-N-1098-0003,FDA,FDA-2000-N-1098,Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents; Confirmation of Effective Date,Rule,Confirmation of Effective Date,2015-11-05T05:00:00Z,2015,11,2001-04-23T04:00:00Z,,2025-06-13T00:39:05Z,01–9873,0,0,09000064804edc16